A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload

Journal of Magnetic Resonance Imaging

Volumn 18, Issue 1, 2003, Pages 33-39

  Westwood, Mark ^a   Anderson, Lisa J ^a   Firmin, David N ^a   Gatehouse, Peter D ^a   Charrier, Clare C ^a   Wonke, Beatrix ^b   Pennell, Dudley J ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Anemia; Cardiomyopathy; Diagnosis; Heart failure; Magnetic resonance imaging; Thalassemia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANEMIA; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEART FAILURE; HUMAN; INTERMETHOD COMPARISON; IRON OVERLOAD; MAGNETIC FIELD; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; TECHNIQUE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; FEMALE; HUMANS; IRON; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM;

EID: 0037482887     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10332     Document Type: Article

References (12)

1. Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet 1989;2:27-30.
2. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous beta-thalassaemia. N Engl J Med 1994;331:574-578.
3. Modell B, Khan M, Darlison M. Survival in beta thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000;355:2051-2052.
4. Aldouri MA, Wonke B, Hoffbrand AV, et al. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol 1990;84:113-117.
5. Wacker P, Halperin D, Balmer-Ruedin D, et al. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassaemia major. Chest 1993;103:1276-1278.
6. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassaemia. Blood 2000;95:1229-1236.
7. Mavrogeni SI, Gotsis ED, Markussis V, et al. T2 relaxation time study of iron overload in b-thalassemia. MAGMA 1998;6:7-12.
8. Anderson LJ, Holden S, Davies B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
9. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron levels and ventricular function in beta thalassemia. Lancet 2002;360:516-520.
10. Li D, Oellerich WF, Beck G, Gropler RJ. Assessment of myocardial response to pharmacologic interventions using an improved MR imaging technique to estimate T2* values. AJR Am J Roentgenol 1999;172:141-145.
11. Wacker CM, Bock M, Hartlep AW, et al. Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T2* and T1 measurements. Magn Reson Med 1999;41:686-695.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307310.